SNPHY:OTCMKTS
Santen Pharmaceutical ADR Representing Ord Shs
$11.01
arrow_upward
+1.01%(+0.11) 1D
Oct 19, 4:00:00 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for SNPHY...
Open
$11.34
High
$11.34
Low
$11.01
Mkt. cap
556.48B
Avg. vol.
2.73K
Volume
3.02K
52-wk high
$13.92
52-wk low
$9.22
Beta
0.49
Shares outstanding
322.31M
No. of employees
4K
Open
$11.34
High
$11.34
Low
$11.01
Mkt. cap
556.48B
Avg. vol.
2.73K
Volume
3.02K
52-wk high
$13.92
52-wk low
$9.22
Beta
0.49
Shares outstanding
322.31M
No. of employees
4K
News stories
From web sources and news partners
BigGo Finance
·
12 minutes ago
Dow Falls 36 Points for Second Straight Session as Oil Rally Weighs, AI-Related Buying Provides Support
Bloomberg
·
57 minutes ago
US Stock Futures Edge Higher After Chipmaker Rally: Markets Wrap
TradingView
·
56 minutes ago
Nasdaq Jumps Past 1 Percent as VIX Swings While Dow Dips Below Its 50-Day Line
Investing.com
·
2 hours ago
U.S. stocks mixed at close of trade; Dow Jones Industrial Average down 0.07%
Profile
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
About Santen Pharmaceutical ADR Representing Ord Shs
CEOAkira Kurokawa | Shigeo Taniuchi
Employees3.97K
Founded1890
HeadquartersOsaka, Kansai, Japan
SectorPharmaceutical industry
Websitesanten.com